Effect of a multitarget therapy with prednisolone, mycophenolate mofetil, and tacrolimus in a patient with type B insulin resistance syndrome complicated by lupus nephritis
Open Access
- 15 October 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Modern Rheumatology Case Reports
- Vol. 6 (1) , 41-46
Abstract
Type B insulin resistance syndrome (TBIR) is a rare autoimmune disease characterised by autoantibodies targeting insulin receptors. TBIR is often complicated by systemic lupus erythematosus (SLE). We describe the case of a 59-year-old Japanese man with TBIR complicated with lupus nephritis (LN), who presented with nephrotic syndrome and severe hypoglycaemia. Treatment with prednisolone (PSL), mycophenolate mofetil (MMF), and tacrolimus (TAC) resulted in improved SLE activity and glucose intolerance with the reduction of anti-insulin receptor autoantibodies. To the best of our knowledge, this is the first reported case of TBIR complicated with LN that was successfully treated using multitarget therapy with PSL, MMF, and TAC.Keywords
This publication has 39 references indexed in Scilit:
- Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor AutoantibodiesThe Journal of Clinical Endocrinology & Metabolism, 2010
- Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritisLupus, 2010
- Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell helpClinical and Experimental Immunology, 2009
- Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprineLupus, 2009
- Renal Involvement in Primary Sjögren's SyndromeClinical Journal of the American Society of Nephrology, 2009
- Successful Treatment of Class V+IV Lupus Nephritis with Multitarget TherapyJournal of the American Society of Nephrology, 2008
- Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an updateJournal of Clinical Pathology, 2007
- Treatment of systemic lupus erythematosus–associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetilArthritis & Rheumatism, 2003
- Clinical Course of the Syndrome of Autoantibodies to the Insulin Receptor (Type B Insulin Resistance)Medicine, 2002
- Tubulointerstitial Disease in Lupus Nephritis: Relationship to Immune Deposits, Interstitial Inflammation, Glomerular Changes, Renal Function, and PrognosisNephron, 1986